Hong X. Dai
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
SSGJ-601 versus Ranibizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion: 52-Week Results from a Phase 3 Study.
Journal: Ophthalmology. Retina
Published: March 30, 2026
Intravitreal aflibercept 8 mg in patients with neovascular age-related macular degeneration from China: 48-week results from the PULSAR trial.
Journal: International journal of retina and vitreous
Published: March 19, 2026
Effectiveness of a comprehensive nursing prevention and control system for respiratory infections in fever clinics in the era of co-existence of multiple pathogens.
Journal: Frontiers in public health
Published: November 06, 2025
Efficacy and safety of anti-VEGF monoclonal antibody 601 for macular oedema in retinal vein occlusion: two phase IIa randomised clinical trials.
Journal: The British journal of ophthalmology
Published: May 22, 2025
Efficacy and Safety of Efdamrofusp Alfa with Personalized Dosing Intervals in Neovascular Age-Related Macular Degeneration: A Phase II Trial.
Journal: Ophthalmology science
Published: February 08, 2025
Simultaneous inhibition of fibroblast growth factor-2 and vascular endothelial growth factor-a with RC28-E in diabetic macular edema: a phase 2 randomised trial.
Journal: The British journal of ophthalmology
Published: June 12, 2024
Safety and Efficacy of Multiple Escalating Doses of RC28-E for Neovascular Age-Related Macular Degeneration: A Phase 1b Trial.
Journal: Ophthalmology and therapy
Published: May 13, 2024
Efficacy and Safety of Efdamrofusp Alfa versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration: A Randomized, Double-Masked, Active-Controlled, Noninferiority, Phase II Trial.
Journal: Ophthalmology. Retina
Published: December 22, 2023
Visual impairment and blindness caused by retinal diseases: A nationwide register-based study.
Journal: Journal of global health
Published: November 03, 2023
Varenicline solution nasal spray for dry eye disease in Chinese patients: a randomized phase 3 trial.
Journal: The Lancet regional health. Western Pacific
Published: October 09, 2023
Chinese Guideline on the Management of Polypoidal Choroidal Vasculopathy (2022).
Journal: Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih
Published: June 01, 2023
Perfluorohexyloctane Eye Drops for Dry Eye Disease Associated With Meibomian Gland Dysfunction in Chinese Patients: A Randomized Clinical Trial.
Journal: JAMA ophthalmology
Published: March 17, 2023
Last Updated: 09/26/2026